| Baseline characteristics | TAVI matched cases (n=100) | Combined interventions (n=10) | p Value |
|---|---|---|---|
| Age (years) | 83.5±5.8 | 82.3±7.8 | 0.67 |
| BMI (kg/m2) | 24.8±4.8 | 26.1±4.0 | 0.28 |
| CHADS2 score (points) | 2.6±0.8 | 2.8±1.5 | 0.84 |
| Creatinine clearance (mL/min) | 44.4±19 | 41.8±13 | 0.81 |
| Female gender | 59/100 (59%) | 6/10 (60%) | 1 |
| Coronary artery disease | 65/100 (65%) | 9/10 (90%) | 0.16 |
| Prior myocardial infarction | 14/100 (14%) | 4/10 (40%) | 0.23 |
| Prior CABG | 15/100 (15%) | 3/10 (30%) | 0.21 |
| Prior stroke | 12/100 (12%) | 1/10 (10%) | 1 |
| LV-EF (%) | 49±17 | 59±10 | 0.12 |
| AVA (cm2) | 0.5±0.2 | 0.6±0.2 | 0.38 |
| Mean transvalvular aortic gradient | 41±18 | 54±17 | 0.055 |
| Logistic EURO score I (%) | 30.9±16.6 | 22.3±11.1 | 0.17 |
| Logistic EURO score II (%) | 11.3±8.1 | 11.2±7.3 | 0.90 |
| STS score (%) | 10.5±5.7 | 10.9±6.6 | 0.98 |
| Atrial fibrillation | 37/100 (37%) | 10/10 (100%) | 0.0001 |
AVA, aortic valve area; BMI, body mass index; CABG, coronary artery bypass graft; CHADS, congestive heart failure, age, diabetes, stroke; LV-EF, left ventricular ejection fraction; TAVI, transcatheter aortic valve implantation.